share_log

4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S

4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S

4:持股變動聲明-高管 DOW GEOFFREY S
美股sec公告 ·  05/21 20:20
Moomoo AI 已提取核心訊息
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed the purchase of 85,000 shares of the company's common stock through a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Dow's direct holdings in the company increased to 762,625 shares. The transactions are reported as exercises or conversions of derivative securities, indicating a potential increase in the executive's stake in the company.
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed the purchase of 85,000 shares of the company's common stock through a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Dow's direct holdings in the company increased to 762,625 shares. The transactions are reported as exercises or conversions of derivative securities, indicating a potential increase in the executive's stake in the company.
60 Degrees Pharmicals總裁兼首席執行官傑弗裏·陶通過一系列交易完成了對公司85,000股普通股的收購。這些收購發生在2024年4月12日至2024年5月16日之間,價格從每股0.223美元到0.2668美元不等。這些交易之後,陶氏在該公司的直接持股量增加到762,625股。這些交易被報告爲衍生證券的行使或轉換,這表明該高管在公司的股份可能增加。
60 Degrees Pharmicals總裁兼首席執行官傑弗裏·陶通過一系列交易完成了對公司85,000股普通股的收購。這些收購發生在2024年4月12日至2024年5月16日之間,價格從每股0.223美元到0.2668美元不等。這些交易之後,陶氏在該公司的直接持股量增加到762,625股。這些交易被報告爲衍生證券的行使或轉換,這表明該高管在公司的股份可能增加。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息